Prevalence of genital and oral human papillomavirus infection among psoriasis patients on biologic therapy

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023736%3A_____%2F22%3A00013439" target="_blank" >RIV/00023736:_____/22:00013439 - isvavai.cz</a>
Alternative codes found
RIV/00064173:_____/22:43923730 RIV/00216208:11120/22:43923730 RIV/00216208:11130/22:10445442 RIV/00216208:11310/22:10445442 RIV/00064211:_____/22:W0000006
Result on the web
<a href="https://doi.org/10.1111/dth.15735" target="_blank" >https://doi.org/10.1111/dth.15735</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1111/dth.15735" target="_blank" >10.1111/dth.15735</a>

Result language
angličtina
Original language name
Prevalence of genital and oral human papillomavirus infection among psoriasis patients on biologic therapy
Original language description
Current knowledge about human papillomavirus (HPV) infection in psoriasis patients treated with biologics is limited. In this study we evaluated the prevalence of oral and genital HPV infection in psoriasis patients treated with biologics or topical therapy for at least 6 months. The presence of HPV DNA in oral rinse and genital smears was evaluated.
Czech name
—
Czech description
—

Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30205 - Hematology

Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year
2022
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)